
### ðŸ«€ Valvular Heart Disease: Infective Endocarditis Prophylaxis

#### âœ… True Statements
1. **Antimicrobial prophylaxis is not indicated** for patients with **mitral regurgitation** due to **myxomatous degeneration (mitral valve prolapse)** before dental procedures.
2. **Current guidelines recommend antimicrobial prophylaxis** only for dental procedures involving **manipulation of gingival tissue**, **periapical regions of teeth**, or **perforation of the oral mucosa**, and only in **specific high-risk patients**.
3. **High-risk conditions** for which **infective endocarditis prophylaxis is indicated** include:
   - History of **infective endocarditis**
   - **Cardiac transplantation** with valve regurgitation due to a structurally abnormal valve
   - **Prosthetic heart valve**, including transcatheter-implanted prostheses and homografts
   - **Cardiac valve repair** with prosthetic material, including annuloplasty rings, chords, and clips
   - **Left ventricular assist device (LVAD)**
   - **Unrepaired cyanotic congenital heart disease**
   - **Repaired congenital heart disease with residual defects** at or adjacent to the site of a prosthetic patch or device
   - **Congenital heart defect repaired with prosthetic material** (surgical or catheter based) within the previous 6 months
4. For patients in whom prophylaxis is indicated, **oral amoxicillin 2 g** taken **30 to 60 minutes** before a dental procedure is the recommended regimen.
5. For patients with a **severe penicillin allergy**, **azithromycin**, **clarithromycin**, or **doxycycline** are acceptable alternatives for prophylaxis.
6. For patients with a **non-severe penicillin allergy**, **cephalexin** or another **first- or second-generation oral cephalosporin** is recommended.
7. **Infective endocarditis prophylaxis is no longer recommended** for a broad population and is now **limited to specific high-risk groups**.
8. **Antimicrobial prophylaxis would not be beneficial** in patients with **mitral valve prolapseâ€“related mitral regurgitation** undergoing dental procedures.

#### ðŸ’¬ Extra
1. The patient described has **mitral valve prolapse** and **mitral regurgitation**, which are **no longer considered high-risk** for infective endocarditis per updated guidelines.
2. Antimicrobial prophylaxis was once recommended for a **broader population**, but it is now restricted to only patients with **specific cardiac conditions** undergoing **certain dental procedures**.
3. This list of high-risk indications is consistent across both the **Answer and Critique** and **Related Text**.
4. Oral amoxicillin remains the **first-line agent** unless contraindicated.
5. Severe penicillin allergy includes a history of **anaphylaxis**, **angioedema**, or **urticaria** with penicillin or ampicillin.
6. Cephalosporins are used if the allergy to penicillin is **non-severe** (e.g., rash without systemic symptoms).

---

#### ðŸ“– Related Text
MKSAP 19: Cardiovascular Medicine â€” Valvular Heart Disease, Infective Endocarditis

---

### ðŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Infective endocarditis is a common complication** of **valvular heart disease**.
2. **Antimicrobial prophylaxis** is only indicated for **high-risk patients** undergoing **dental procedures** involving **manipulation of gingival tissue**, **periapical regions of teeth**, or **perforation of the oral mucosa**.
3. The **same high-risk cardiac conditions** listed in the main text apply for determining **prophylaxis eligibility** before dental procedures.
4. **Cardiac implantable electronic deviceâ€“related infections** are discussed separately in dedicated guidance on device infections.
5. The **diagnosis and management** of infective endocarditis are covered in sections beyond prophylaxis guidance.

#### ðŸ’¬ Extra (for Related Text)
1. Endocarditis risk increases in the presence of structural valve disease, especially when turbulence or damage to the endocardium occurs.
2. These procedures create microtrauma or transient bacteremia, which is the rationale for targeting high-risk cardiac conditions.
3. The same list of high-risk indicationsâ€”prosthetic valves, previous endocarditis, certain congenital heart diseasesâ€”is echoed across all guideline-based sources.
4. Device-related infections (e.g., pacemakers, ICDs) are managed under separate protocols because they have distinct microbiologic and procedural risk profiles.
5. Diagnosis and treatment of active infective endocarditis involve blood cultures, imaging (e.g., transesophageal echocardiography), and prolonged intravenous antibiotics or surgery.

#### ðŸ”· Tags
#Cardiology #ValvularHeartDisease #InfectiveEndocarditis #DentalProphylaxis #AmbulatoryCare

#### ðŸ“™ Reference
Wilson WR, Gewitz M, Lockhart PB, et al; American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and the Council on Quality of Care and Outcomes Research. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. *Circulation*. 2021;e963-e978. PMID: 33853363. doi:10.1161/CIR.0000000000000969

#### ðŸ†” Question ID
CVQQQ24016

#### ðŸ•’ Last Updated
January 2025

<!-- Infective Endocarditis Prophylaxis Table -->
<table>
  <caption><strong>Prophylactic Infective Endocarditis Regimens for Adults at Highest Risk for an Adverse Outcome Before a Dental Procedure</strong></caption>
  <thead>
    <tr>
      <th>Situation</th>
      <th>Agent</th>
      <th>Dosage<sup>a</sup></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Oral</td>
      <td>Amoxicillin</td>
      <td>2 g</td>
    </tr>
    <tr>
      <td rowspan="2">Unable to take oral medication</td>
      <td>Ampicillin</td>
      <td>2 g IM or IV</td>
    </tr>
    <tr>
      <td><em>or</em> Cefazolin or ceftriaxone</td>
      <td>1 g IM or IV</td>
    </tr>
    <tr>
      <td rowspan="4">Allergic to penicillin or ampicillinâ€”oral</td>
      <td>Cephalexin<sup>b,c</sup></td>
      <td>2 g</td>
    </tr>
    <tr>
      <td><em>or</em> Azithromycin or clarithromycin</td>
      <td>500 mg</td>
    </tr>
    <tr>
      <td><em>or</em> Doxycycline</td>
      <td>100 mg</td>
    </tr>
    <tr>
      <td colspan="3"></td>
    </tr>
    <tr>
      <td>Allergic to penicillin or ampicillin and unable to take oral medication</td>
      <td>Cefazolin or ceftriaxone</td>
      <td>1 g IM or IV</td>
    </tr>
  </tbody>
</table>

<p><sup>IM</sup> = intramuscular; <sup>IV</sup> = intravenous.</p>
<p><sup>a</sup>Regimen consists of a single dose 30 to 60 minutes before the dental procedure, or if inadvertently not administered, drug may be given up to 2 hours after the procedure.</p>
<p><sup>b</sup>Or other first- or second-generation oral cephalosporin in equivalent adult dosage.</p>
<p><sup>c</sup>Cephalosporins should not be used in an individual with a history of anaphylaxis, angioedema, or urticaria with penicillins or ampicillin.</p>
<p><strong>Source:</strong> Wilson WR, Gewitz M, Lockhart PB, et al; American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee... Circulation. 2021; e963â€“e978. 
<a href="https://doi.org/10.1161/CIR.0000000000000969">PMID: 33853363</a></p>
